av/merrimack-pharmaceuticals--big.svg

NASDAQ:MACK

Merrimack Pharmaceuticals, Inc.

  • Stock

USD

Last Close

14.75

28/03 20:00

Market Cap

189.75M

Beta: 1.80

Volume Today

404.06K

Avg: 70.31K

PE Ratio

−152.04

PFCF: −135.35

  • industry

    Biotechnology
  • exchange

    NASDAQ Global Market
  • website

    www.merrimack.com
  • ipo date

    Mar 29, 2012
  • currency

    USD

Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts.

Earnings

Earnings per Share (Estimate*)

-4-3-2-12015-05-072017-05-102019-05-102021-05-062023-05-04

Revenue (Estimate*)

50M100M150M200M2015-05-072017-05-102019-05-102021-05-062023-05-04

*Estimate based on analyst consensus

Please Sign In To Use The Chat

The chat is only available for registered users, please sign in or create your free account.